EUVIMEDEUVIMED entdecken
Übersichtsarbeit

mTOR Signalling in Arbovirus Infections: Molecular Mechanisms and Therapeutic Opportunities

Suad A Alghamdi, Mohammed Alissa, Abdullah Alghamdi iD

Reviews in Medical Virology · 2025

DOI: 10.1002/rmv.70037 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Reviews in Medical Virology, 2025. Verfasst von Suad A Alghamdi und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Laboratory, College of Applied Medical Sciences, Prince Sattam Bin Abdulaziz University, Al-Kharj, Saudi Arabia. Hauptthemen laut MEDLINE: Signal Transduction, TOR Serine-Threonine Kinases, Arboviruses, Arbovirus Infections. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 80 Literaturangaben. Gefördert von: Prince Sattam Bin Abdulaziz University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Arboviruses, including dengue virus (DENV), Zika virus (ZIKV), Japanese encephalitis virus (JEV), and West Nile virus (WNV), are vector‐borne pathogens that exploit the mammalian target of rapamycin (mTOR) signalling pathway to optimise host cellular environments for replication, immune evasion, and pathogenesis. These viruses manipulate mTOR complexes through specific viral proteins, such as DENV NS5 activating mTORC2 to suppress apoptosis and ZIKV NS4A/NS4B inhibiting Akt‐mTORC1 signalling to impair neurogenesis while promoting autophagy. JEV NS1/NS1′ disrupts the blood‐brain barrier by inducing autophagy‐mediated degradation of tight junction proteins via mTOR suppression, contributing to encephalitis. These interactions result in severe pathological outcomes, including immune evasion, metabolic reprogramming, apoptosis suppression, and neurological disorders like microcephaly. Targeting mTOR has emerged as a promising therapeutic approach for arbovirus infections. Rapamycin and its derivatives reduce viral replication and improve survival in preclinical models, while repurposed drugs like niclosamide and chloroquine exhibit antiviral effects against ZIKV. ATP‐competitive inhibitors such as Torin‐1 and natural compounds like resveratrol expand the therapeutic landscape. Combination therapies pairing mTOR inhibitors with antivirals or immune modulators may provide synergistic benefits. This review highlights the molecular mechanisms underlying arbovirus manipulation of mTOR signalling and emphasises the potential of tailored therapeutic interventions targeting these pathways to mitigate arbovirus‐associated diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Signal TransductionTOR Serine-Threonine KinasesArbovirusesArbovirus InfectionsHumansAnimalsVirus ReplicationHost-Pathogen InteractionsAntiviral AgentsMTOR Inhibitors

Substanzen

TOR Serine-Threonine KinasesAntiviral AgentsMTOR protein, humanMTOR Inhibitors

Autor:innen und Institutionen

  • Department of Medical Laboratory, College of Applied Medical Sciences, Prince Sattam Bin Abdulaziz University, Al-Kharj, Saudi Arabia.

ORCID-Profile: Abdullah Alghamdi

Förderung

  • Prince Sattam Bin Abdulaziz University

Zitieren

APA

Alghamdi, S. A., Alissa, M., & Alghamdi, A. (2025). mTOR Signalling in Arbovirus Infections: Molecular Mechanisms and Therapeutic Opportunities. Reviews in Medical Virology. https://doi.org/10.1002/rmv.70037

Vancouver

Alghamdi SA, Alissa M, Alghamdi A. mTOR Signalling in Arbovirus Infections: Molecular Mechanisms and Therapeutic Opportunities. Reviews in Medical Virology. 2025. doi:10.1002/rmv.70037

BibTeX
@article{Alghamdi2025,
  author = {Alghamdi, Suad A and Alissa, Mohammed and Alghamdi, Abdullah},
  title = {mTOR Signalling in Arbovirus Infections: Molecular Mechanisms and Therapeutic Opportunities},
  journal = {Reviews in Medical Virology},
  year = {2025},
  doi = {10.1002/rmv.70037}
}
Kostenlos starten →